Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiparameter analysis using flow cytometry as additional tool for bladder cancer diagnosis]

R Knuechel1, W Wieland, H Nicolai

  • 1Institut für Pathologie der Universität Regensburg.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.

Prostate cancer and prostatic diseases·2016
Same author

Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.

Cancer microenvironment : official journal of the International Cancer Microenvironment Society·2015
Same author

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.

Cancer microenvironment : official journal of the International Cancer Microenvironment Society·2014
Same author

Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma.

Journal of cancer research and clinical oncology·2011
Same author

Detection of differentially expressed genes in human bladder cancer cells using arbitrarily primed PCR of RNA.

International journal of oncology·2011
Same author

[Video-based teaching in pathology. Experience gained in the last 3 years at the RWTH Aachen University].

Der Pathologe·2010

Multiparameter analysis using urothelial associated-glycoproteins (UAGAb) and cytokeratin antibodies aids bladder cancer classification. This method improves tumor cell selection for precise S-phase fraction determination and tetraploid tumor identification.

Area of Science:

  • Urothelial Carcinogenesis
  • Cancer Biomarkers
  • Flow Cytometry

Context:

  • Accurate bladder cancer classification is crucial for effective treatment.
  • Current classification methods may require refinement for improved precision.
  • Multiparameter analysis offers a potential avenue for enhanced diagnostic capabilities.

Purpose:

  • To explore multiparameter analysis using urothelial associated-glycoproteins (UAGAb) and cytokeratin antibodies (CKAb) for bladder cancer classification.
  • To evaluate the utility of UAGAb in conjunction with DNA staining for phenotyping bladder tumors.
  • To assess the impact of UAGAb-based cell selection on determining tumor S-phase fraction and ploidy.

Summary:

  • This study utilized single-cell suspensions from 21 bladder cancer specimens, applying multiparameter analysis with UAGAb (Uro1, -5, -9, -10) and CKAb (KL1) alongside DNA staining.

Related Experiment Videos

  • Preliminary findings indicate that the proportion of UAGAb-positive cells should be correlated with the pan-urothelial marker Uro5 due to variable urothelial cell percentages.
  • UAGAb-based selection of tumor cells enhanced the precision of S-phase fraction determination and facilitated the identification of tetraploid tumors.
  • Impact:

    • This methodology shows promise for improved classification of early-stage bladder cancers (pTa and pT1).
    • The findings contribute to the development of more precise diagnostic tools for bladder urothelial carcinoma.
    • Prospective analysis of pTa and pT1 tumors using this approach has commenced, paving the way for further validation.